You can buy or sell VBLT and other stocks, options, ETFs, and crypto commission-free!
Vascular Biogenics Ltd. Ordinary Shares, also called Vascular Biogenics, is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Read More Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.
52 Week High
52 Week Low
— per share
Expected Aug 11, Pre-Market